v3.26.1
Supplementary Balance Sheet Information (Tables)
 6 Months Ended
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Property and Equipment

Property and equipment consist of the following (in thousands):

 

 

As of

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Lab equipment

 

$

7,009

 

 

$

6,423

 

Leasehold improvements

 

 

28,409

 

 

 

28,265

 

Computer equipment

 

 

1,060

 

 

 

1,075

 

Furniture and fixtures

 

 

1,135

 

 

 

1,122

 

Software

 

 

325

 

 

 

325

 

Vehicles

 

 

96

 

 

 

96

 

Construction in process

 

 

4

 

 

 

27

 

 

 

38,038

 

 

 

37,333

 

Less accumulated depreciation

 

 

(14,235

)

 

 

(12,516

)

   Total property and equipment, net

 

$

23,803

 

 

$

24,817

 
Schedule of Intangible Assets, Excluding Goodwill

Intangible assets, excluding goodwill, consist of the following (in thousands):

 

 

June 30, 2026

 

 

December 31, 2025

 

 

 

Cost

 

 

Accumulated
Amortization

 

 

Net Carrying Value

 

 

Cost

 

 

Accumulated
Amortization

 

 

Net Carrying Value

 

Intangible assets subject to amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Patents

 

$

1,860

 

 

$

(879

)

 

$

981

 

 

$

1,953

 

 

$

(1,003

)

 

$

950

 

Purchased technology

 

 

16,900

 

 

 

(15,022

)

 

 

1,878

 

 

 

16,900

 

 

 

(14,084

)

 

 

2,816

 

Intangible assets not subject to
    amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks

 

 

120

 

 

 

—

 

 

 

120

 

 

 

117

 

 

 

—

 

 

 

117

 

   Total

 

$

18,880

 

 

$

(15,901

)

 

$

2,979

 

 

$

18,970

 

 

$

(15,087

)

 

$

3,883

 
Schedule of Future Estimated Amortization Expense of Intangible Assets

Future estimated amortization expense of intangible assets is (in thousands):

 

As of
June 30, 2026

 

Remainder of 2026

 

$

1,008

 

2027

 

 

1,056

 

2028

 

 

110

 

2029

 

 

110

 

2030

 

 

108

 

2031 and thereafter

 

 

467

 

Total

 

$

2,859

 

 
Schedule of Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

 

 

As of

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Compensation related accruals

 

$

7,383

 

 

$

7,834

 

Accrued clinical trial expenses

 

 

799

 

 

 

767

 

Other expenses

 

 

2,229

 

 

 

2,432

 

    Total accrued liabilities

 

$

10,411

 

 

$

11,033